Objective Mucin 1 (MUC1)and Thomsen-Friedenreich related antigens (TFRA)gene play an important role in the occurrence and development of tumor,so we will discuss its research advancements and clinical applications below. Methods Foreign and native related literatures published in recent 10 years were retrieved,and a further exploration on the expression relationship and clinical research progression of MUC1 and TFRA were reviewed. Results MUC1 and TFRA expressed in a high degree of specificity in malignant tumors,and their expressions interacted with each other. Many MUC1 related vaccines had been introduced to clinical in recent years,and some drugs based on TFRA had been put into clinical experiment as gene therapy methods too. Conclusions MUC1 and TFRA may be used as new target antigens of specific immunotherapy for malignant tumor. That they express in high or low level is closely related to tumor biological behavior and prognosis, moreover, they are important to the diagnosis and treatment of cancer.